Epidemiology of Invasive Fungal Infections in Patients with Acquired Immunodeficiency Syndrome at a Reference Hospital for Infectious Diseases in Brazil

Mycopathologia

Volumn 178, Issue 1-2, 2014, Pages 71-78

  de Oliveira, Renata Buccheri ^a   Atobe, Jane Harumi ^a   Souza, Simone Aparecida ^a   de Castro Lima Santos, Daniel Wagner ^a,b,c  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Commission of Hospital Infection Control Institute of Infectious Diseases Emílio Ribas ^*  (Brazil)

Author keywords

AIDS; Candidemia; Cryptococcosis; Emerging opportunistic yeast infections; Histoplasmosis; Invasive fungal infections

Indexed keywords

ASPERGILLUS; CANDIDA; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; CLASSIFICATION; COMPLICATION; FEMALE; FUNGUS; HOSPITAL; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDY; SURVIVAL; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; FEMALE; FUNGI; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84904391237     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-014-9755-3     Document Type: Article

References (23)

1. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis. 2001;33(5): 641-7.
2. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36(1): 1-53.
3. Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis. 1992;14(1): 141-8.
4. Burckhardt B, Sendi P, Pfluger D, Zimmerli W, Nüesch R, Bucher HC, et al. Rare AIDS-defining diseases in the Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1999;18(6): 399-402.
5. Haddad NE, Powderly WG. The changing face of mycoses in patients with HIV/AIDS. AIDS Read. 2001: 11(7): 365-368, 375-378.
6. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, Curran JW. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17): 1-19.
7. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren MI, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United Stated in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 1): S5-14.
8. Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1, 630 autopsies performed between 1984 and 2002. Am J Clin Pathol. 2009;132(2): 221-7.
9. Prado M, Silva MB, Laurenti R, Travassos L, Taborda CP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009;104(3): 513-21.
10. Antinori S, Ridolfo AL, Fasan M, Magni C, Galimberti L, Milazzo L, et al. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med. 2009;10(1): 6-11.
11. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the global burden of cryptococcal meningitis among persons living with HIV (AIDS). AIDS. 2009;23: 525-30.
12. Vidal JE, Gerhardt J, de Miranda EJP, Dauar RF, Oliveira Filho GS, de Oliveira ACP, Boulwaref DR. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73: 68-73.
13. Vidal JE, de Oliveira ACP, Dauar RF, Boulwared DR. Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America. Braz J Infect Dis. 2013;17(3): 353-62.
14. McKinsey D. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS. 1998;12(10): 775-81.
15. Daher EF, Silva GB Jr, Barros FAS, Takeda CFV, Mota RMS, Ferreira MT, et al. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health. 2007;12(9): 1108-15.
16. Mansilla M, Da Silveira AD, Laca HN, Balleste R, Braselli A. Clinical manifestation of aids-associated histoplasmosis in Uruguay. In: 12th International conference on AIDS. June 28-July 3 Geneva. 1998. p. 307.
17. Benard G, Duarte AJS. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis. 2000;31(4): 1032-9.
18. Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol. 1994;30: 904-8.
19. Corbel MJ, Eades SM. Factors determining the susceptibility of mice to experimental phycomycosis. J Med Microbiol. 1975;8(4): 551-64.
20. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004;36(8): 564-9.
21. Gross JW, Kan VL. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS. 2008;22(6): 793-5.
22. Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Perez MJ, Sanchez-Somolinos M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11): 1625-34.
23. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE. 2013;8(3): e59373. doi: 10. 1371/journal. pone. 0059373.